内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Yocca Frank. Insider active across 1 company, notably BioXcel Therapeutics, Inc.. Cumulatively, 20 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €1.4m. History available since 20 January 2023. The latest transaction was disclosed on 20 May 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Yocca Frank
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
35 股Common StockSEC:0001104659-26-075300:0
6,845 股@ US$1.0850.021% mcap0.5% 占其流量Common StockSEC:0001104659-26-065841:1
17,500 股Common StockSEC:0001104659-26-065841:0
33 股Common StockSEC:0001104659-26-028718:0
33 股Common StockSEC:0001104659-25-121300:0
33 股Common StockSEC:0001104659-25-090514:0
35 股Common StockSEC:0001104659-25-090514:1
4,375 股Common StockSEC:0001104659-25-069702:0
33 股Common StockSEC:0001104659-25-059981:0
31 股Common StockSEC:0001104659-25-024532:0
521 股Common StockSEC:0001104659-24-129457:0
21,250 股Common StockSEC:0001104659-24-106062:0
521 股Common StockSEC:0001104659-24-100752:0
521 股Common StockSEC:0001104659-24-073004:0
521 股Common StockSEC:0001104659-24-044857:0
521 股Common StockSEC:0001104659-23-126926:0
521 股Common StockSEC:0001104659-23-101641:0
521 股Common StockSEC:0001104659-23-072398:0
2,084 股Common StockSEC:0001104659-23-033406:0
50,000 股@ US$30.0099.5% 占其流量Common StockSEC:0001104659-23-006298:0
About Yocca Frank
Yocca Frank is an insider linked to BioXcel Therapeutics, Inc. (XNAS), where the listed role is Chief Scientific Officer. The 20 filings recorded cover, in the sampled recent filings, sales totaling EUR 1390934 between 2023-01-24 and 2026-06-17, with the transaction nature listed as option exercise.